Search results
Results from the WOW.Com Content Network
A drug used to treat HIV infections can also effectively prevent them, a new clinical trial demonstrates. Image credit: luza studios/Getty Images. This article originally appeared on Medical News ...
A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global health official told Reuters on Tuesday. The ambition is to start ...
Bangladesh also has a high tuberculosis (TB) burden, with 102 new cases per 100,000 people in 2005, according to the World Health Organization.HIV infects about 0.1 percent of adult TB patients in Bangladesh and HIV-TB co-infections complicate treatment and care for both diseases.
Even despite new waivers from the State Department on 6 February, which explicitly included HIV care and treatment (but not prevention), thousands of staff who handle these projects have already ...
As of March 2016, there were 31,620 reported cases of Taiwanese nationals testing positive for HIV/AIDS. [24] Currently, HIV/AIDS patients who are Taiwanese nationals receive free medical care (including HAART therapies) from the state. Non-governmental organizations have set up "AIDS Half-Way Houses" for homeless patients. The ratio of ...
The combination of Rekambys and Vocabria injection is intended for maintenance treatment of adults who have undetectable HIV levels in the blood (viral load less than 50 copies/ml) with their current ARV treatment, and when the virus has not developed resistance to certain class of anti-HIV medicines called non-nucleoside reverse transcriptase ...
Treatment Action Group (TAG) is a U.S.-based organization that has been prominent within the movement of HIV/AIDS activism.Being formed in 1991, it has possessed the goals of working with worldwide efforts to increase research on treatments for HIV and for deadly co-infections that affect individuals with HIV, such as hepatitis C and tuberculosis, as well as spur on greater access to and ...
From injectables to side effects to PrEP, our annual Treatment Guide will answer all your questions about the treatment and prevention of HIV.